These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32619180)

  • 1. Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer.
    Kaur N; Goyal A; Sindhu RK
    Anticancer Agents Med Chem; 2020; 20(16):1895-1907. PubMed ID: 32619180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Antibodies in Cancer Therapy.
    Gasser M; Waaga-Gasser AM
    Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art in anti-cancer mAbs.
    Chiavenna SM; Jaworski JP; Vendrell A
    J Biomed Sci; 2017 Feb; 24(1):15. PubMed ID: 28219375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic human monoclonal antibodies against cancer.
    Jarboe J; Gupta A; Saif MW
    Methods Mol Biol; 2014; 1060():61-77. PubMed ID: 24037836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approved monoclonal antibodies for cancer therapy.
    Boyiadzis M; Foon KA
    Expert Opin Biol Ther; 2008 Aug; 8(8):1151-8. PubMed ID: 18613766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Antibodies for the Treatment of Cancer.
    Pento JT
    Anticancer Res; 2017 Nov; 37(11):5935-5939. PubMed ID: 29061772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody].
    Shimodaira H; Komine K; Soeda H; Ishioka C
    Gan To Kagaku Ryoho; 2010 May; 37(5):795-8. PubMed ID: 20495309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.
    Demlova R; Valík D; Obermannova R; ZdraŽilová-Dubská L
    Physiol Res; 2016 Dec; 65(Suppl 4):S455-S462. PubMed ID: 28006927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies in oncology.
    Pillay V; Gan HK; Scott AM
    N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principal therapeutic uses of monoclonal antibodies in oncology].
    Penault-Llorca F; Etessami A; Bourhis J
    Cancer Radiother; 2002 Nov; 6 Suppl 1():24s-28s. PubMed ID: 12587379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
    Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK
    Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic antibodies against cancer.
    Adler MJ; Dimitrov DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.
    Gan HK; Burgess AW; Clayton AH; Scott AM
    Cancer Res; 2012 Jun; 72(12):2924-30. PubMed ID: 22659454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.
    Carvalho S; Levi-Schaffer F; Sela M; Yarden Y
    Br J Pharmacol; 2016 May; 173(9):1407-24. PubMed ID: 26833433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Immunotherapy: The Dawn of Antibody Cocktails.
    Marrocco I; Romaniello D; Yarden Y
    Methods Mol Biol; 2019; 1904():11-51. PubMed ID: 30539465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.